These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 30496777)

  • 1. pH selectively regulates citric acid and lipid production in Yarrowia lipolytica W29 during nitrogen-limited growth on glucose.
    Zhang S; Jagtap SS; Deewan A; Rao CV
    J Biotechnol; 2019 Jan; 290():10-15. PubMed ID: 30496777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrates and oxygen dependent citric acid production by Yarrowia lipolytica: insights through transcriptome and fluxome analyses.
    Sabra W; Bommareddy RR; Maheshwari G; Papanikolaou S; Zeng AP
    Microb Cell Fact; 2017 May; 16(1):78. PubMed ID: 28482902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valorization of Crude Glycerol, Residue Deriving from Biodiesel- Production Process, with the Use of Wild-type New Isolated Yarrowia lipolytica Strains: Production of Metabolites with Pharmaceutical and Biotechnological Interest.
    Sarris D; Sampani Z; Rapti A; Papanikolaou S
    Curr Pharm Biotechnol; 2019; 20(10):881-894. PubMed ID: 30747061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-stat culture for studying the metabolic shifts from oxidative metabolism to lipid accumulation and citric acid production in Yarrowia lipolytica.
    Ochoa-Estopier A; Guillouet SE
    J Biotechnol; 2014 Jan; 170():35-41. PubMed ID: 24316225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yarrowia lipolytica as a potential producer of citric acid from raw glycerol.
    Papanikolaou S; Muniglia L; Chevalot I; Aggelis G; Marc I
    J Appl Microbiol; 2002; 92(4):737-44. PubMed ID: 11966915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of glucose and saturated free-fatty acid mixtures on citric acid and lipid production by Yarrowia lipolytica.
    Papanikolaou S; Galiotou-Panayotou M; Chevalot I; Komaitis M; Marc I; Aggelis G
    Curr Microbiol; 2006 Feb; 52(2):134-42. PubMed ID: 16392008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening various Yarrowia lipolytica strains for citric acid production.
    Carsanba E; Papanikolaou S; Fickers P; Erten H
    Yeast; 2019 May; 36(5):319-327. PubMed ID: 30945772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and optimization of lipid accumulation by Yarrowia lipolytica from glucose under nitrogen depletion conditions.
    Robles-Rodríguez CE; Muñoz-Tamayo R; Bideaux C; Gorret N; Guillouet SE; Molina-Jouve C; Roux G; Aceves-Lara CA
    Biotechnol Bioeng; 2018 May; 115(5):1137-1151. PubMed ID: 29288574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of oxygen availability on the metabolism and morphology of Yarrowia lipolytica: insights into the impact of glucose levels on dimorphism.
    Timoumi A; Bideaux C; Guillouet SE; Allouche Y; Molina-Jouve C; Fillaudeau L; Gorret N
    Appl Microbiol Biotechnol; 2017 Oct; 101(19):7317-7333. PubMed ID: 28879478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic activities of biotechnological interest in Yarrowia lipolytica grown on glycerol in repeated batch cultures.
    Makri A; Fakas S; Aggelis G
    Bioresour Technol; 2010 Apr; 101(7):2351-8. PubMed ID: 19962884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The citric acid production from raw glycerol by Yarrowia lipolytica yeast and its regulation.
    Morgunov IG; Kamzolova SV; Lunina JN
    Appl Microbiol Biotechnol; 2013 Aug; 97(16):7387-97. PubMed ID: 23807667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of the Glycerol Phosphate availability led to concomitant reduction in the citric acid excretion and increase in lipid content and yield in Yarrowia lipolytica.
    Sagnak R; Cochot S; Molina-Jouve C; Nicaud JM; Guillouet SE
    J Biotechnol; 2018 Jan; 265():40-45. PubMed ID: 29102548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of environmental conditions on product formation and morphology of Yarrowia lipolytica.
    Timoumi A; Guillouet SE; Molina-Jouve C; Fillaudeau L; Gorret N
    Appl Microbiol Biotechnol; 2018 May; 102(9):3831-3848. PubMed ID: 29523935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urea and urine are a viable and cost-effective nitrogen source for Yarrowia lipolytica biomass and lipid accumulation.
    Brabender M; Hussain MS; Rodriguez G; Blenner MA
    Appl Microbiol Biotechnol; 2018 Mar; 102(5):2313-2322. PubMed ID: 29383430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering Yarrowia lipolytica for the production of cyclopropanated fatty acids.
    Markham KA; Alper HS
    J Ind Microbiol Biotechnol; 2018 Oct; 45(10):881-888. PubMed ID: 30120620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial lipids and added value metabolites production by Yarrowia lipolytica from pork lard.
    Lopes M; Gomes AS; Silva CM; Belo I
    J Biotechnol; 2018 Jan; 265():76-85. PubMed ID: 29141191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effectors of dimorphism in Yarrowia lipolytica.
    Ruiz-Herrera J; Sentandreu R
    Arch Microbiol; 2002 Dec; 178(6):477-83. PubMed ID: 12420169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aseptic production of citric and isocitric acid from crude glycerol by genetically modified Yarrowia lipolytica.
    Rzechonek DA; Dobrowolski A; Rymowicz W; Mirończuk AM
    Bioresour Technol; 2019 Jan; 271():340-344. PubMed ID: 30292133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid production by Yarrowia lipolytica growing on industrial glycerol in a single-stage continuous culture.
    Papanikolaou S; Aggelis G
    Bioresour Technol; 2002 Mar; 82(1):43-9. PubMed ID: 11848376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Synthesis citric and isocitric acids by Yarrowia lipolytica during yeasts growth on rapeseed oils].
    Kamzolova SV; Finogenova TV; Lunina IuN; Perevoznikova OA; Minachova LN; Morgunov IG
    Mikrobiologiia; 2007; 76(1):26-31. PubMed ID: 17410871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.